4//SEC Filing
SIGMA TAU FINANZIARIA SPA 4
Accession 0001140361-09-021821
CIK 0000812796other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 1:22 PM ET
Size
39.0 KB
Accession
0001140361-09-021821
Insider Transaction Report
Form 4
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Other
Common Stock Warrant (right to buy)
2009-09-24+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2009-09-27Exp: 2014-09-27→ Common Stock (1,976,284 underlying) - Purchase
Common Stock
2009-09-24$0.25/sh+3,952,569$1,000,000→ 45,619,236 total(indirect: Indirect)
Footnotes (3)
- [F1]Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A.
- [F2]This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals? purchase of 3,952,569 shares of common stock on September 24, 2009.
- [F3]The expiration date of the warrant may be accelerated at the Issuer?s option if the Issuers?s common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended.
Documents
Issuer
DOR BIOPHARMA INC
CIK 0000812796
Entity typeother
Related Parties
1- filerCIK 0001092601
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 1:22 PM ET
- Size
- 39.0 KB